SCHEMBL6007442

SCHEMBL6007442

S=Cc1ncncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2320675 0.71
SCHEMBL437703 0.69
SCHEMBL6889110 0.69
SCHEMBL11978709 0.65
SCHEMBL2238608 0.65
SCHEMBL6767656 0.65
SCHEMBL9723365 0.63 HSP90AA1 (0.33)
SCHEMBL687678 0.62
SCHEMBL373166 0.60 HSP90AA1 (0.50)
SCHEMBL6007422 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102134242-A Novel compounds for quickly treating impotence with long-lasting action ZHEJIANG DADE PHARMACEUTICAL GROUP CO LTD 2011-07-27 CN claimed
CN-1712403-A 2-phenyl substituted imidazotriazone compound for treating or preventing from impotence RADIATION MEDICAL INST MILITAR (CN) 2005-12-28 CN claimed
CN-111423457-A 1,9 a-dihydropyrido [2,1-c ] [1,4] thiazine compound and preparation method thereof 深圳职业技术学院 2020-07-17 CN disclosed
CN-105263472-A Topical pharmaceutical composition comprising tenofovir and an antibacterial agent and optionally ciclopirox CIPLA LTD 2016-01-20 CN disclosed
CN-104884063-A Antiretroviral pharmaceutical compositions CIPLA LTD 2015-09-02 CN disclosed
CN-102134242-B Novel compounds for quickly treating impotence with long-lasting action ZHEJIANG DADE PHARMACEUTICAL GROUP CO LTD 2013-08-28 CN disclosed
CN-101553483-B 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors HOFFMANN LA ROCHE 2013-04-17 CN disclosed
CN-101679294-B Non-nucleoside reverse transcriptase inhibitors HOFFMANN LA ROCHE 2012-08-08 CN disclosed
CN-101501002-B Non-nucleoside reverse transcriptase inhibitors HOFFMANN LA ROCHE 2012-06-27 CN disclosed
CN-102134242-A Novel compounds for quickly treating impotence with long-lasting action ZHEJIANG DADE PHARMACEUTICAL GROUP CO LTD 2011-07-27 CN disclosed
CN-101679294-A Non-nucleoside reverse transcriptase inhibitors HOFFMANN LA ROCHE 2010-03-24 CN disclosed
CN-101273020-A NNRT inhibitors HOFFMANN LA ROCHE (CH) 2008-09-24 CN disclosed
EP-1207161-B1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMA CO LTD (JP) 2006-01-18 EP disclosed
CN-1712403-A 2-phenyl substituted imidazotriazone compound for treating or preventing from impotence RADIATION MEDICAL INST MILITAR (CN) 2005-12-28 CN disclosed
US-6777410-B2 SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-08-17 US disclosed
CN-1517790-A Emulsion and material cntaining triazine-thioketone compound for heat development material ��˹���´﹫˾ 2004-08-04 CN disclosed
CN-1517790-A Emulsion and material cntaining triazine-thioketone compound for heat development material ��˹���´﹫˾ 2004-08-04 CN disclosed
US-20040053923-A1 Novel isoindole derivatives BANYU PHARMACEUTICAL CO., LTD. 2004-03-18 US disclosed
US-6608098-B1 Diabetes or obesity, 2-(4-(3-isopropyl-2,5-dioxo-2,3-dihydro-1H-pyrrolo(2,1-a) isoindol-9(5H)-yl)phenoxy)-N-propylacetamide BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-08-19 US disclosed
EP-1207161-A1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-05-22 EP disclosed